US$ 27.85
tirzepatide targets Benefits of Injections A University of Georgia study
Description
Key takeaways Without insurance, tirzepatide can range from $299 per month (for the lowest-dose Zepbound vial paid in cash) to $1,112.16 per month (for brand-name Mounjaro)
The reason is straightforward

If a patient plans to become pregnant, tirzepatide should be discontinued at least one month prior to the intended pregnancy due to its long half-life

For weight loss, tirzepatide acts centrally on appetite regulation centers in the hypothalamus, reducing hunger and increasing satiety signals

6,7,8,9,10 While tirzepatide produces greater weight loss than semaglutide in patients with T2D, 11 data from head-to-head trials comparing these therapies in patients with overweight or obesity are not yet available
